These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31047311)

  • 41. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy.
    Bajwa A; Aziz K; Foster CS
    Retina; 2014 Nov; 34(11):2259-68. PubMed ID: 24999722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uveitis treated with fluocinolone acetonide implants.
    Viola F; Staurenghi G; Ratiglia R
    Arch Ophthalmol; 2009 Jan; 127(1):115-6; author reply 116. PubMed ID: 19139357
    [No Abstract]   [Full Text] [Related]  

  • 43. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
    Bollinger K; Kim J; Lowder CY; Kaiser PK; Smith SD
    Ophthalmology; 2011 Oct; 118(10):1927-31. PubMed ID: 21652079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
    Soubrane G; Behar-Cohen F
    J Fr Ophtalmol; 2015 Feb; 38(2):159-67. PubMed ID: 25601517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thru-the-Trocar Administration of Dexamethasone Intravitreal Implant During 23-G Pars Plana Vitrectomy: A Small Case Series.
    Rodríguez-Valdés PJ; Newman-Sánchez OA; González-Madrigal PM
    Retina; 2015 Nov; 35(11):2411-3. PubMed ID: 26418448
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results].
    Stefaničková J; Strmeň P; Vavrová K; Mrózová L; Krásnik V
    Cesk Slov Oftalmol; 2012 Nov; 68(5):180-8. PubMed ID: 23461369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.
    Heo JW; Cho BJ; Goldstein DA; Sepah YJ; Do DV; Nguyen QD
    Retina; 2016 Nov; 36(11):2124-2131. PubMed ID: 27333235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report.
    Wasielica-Poslednik J; Pfeiffer N; Gericke A
    J Med Case Rep; 2019 Jan; 13(1):21. PubMed ID: 30674351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema.
    Currie CJ; Holden SE; Owens DR
    Curr Med Res Opin; 2017 Oct; 33(sup2):33-43. PubMed ID: 28881150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous dislocation of fluocinolone acetonide implant pellets from their suture struts.
    Itty S; Callanan D; Jones R; Pecen P; Martel J; Jaffe GJ
    Am J Ophthalmol; 2015 May; 159(5):868-76.e1. PubMed ID: 25640410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
    Mruthyunjaya P; Khalatbari D; Yang P; Stinnett S; Tano R; Ashton P; Guo H; Nazzaro M; Jaffe GJ
    Arch Ophthalmol; 2006 Jul; 124(7):1012-8. PubMed ID: 16832025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal disease.
    Comyn O; Lightman SL; Hykin PG
    Curr Opin Ophthalmol; 2013 May; 24(3):248-54. PubMed ID: 23518614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COMBINED VITRECTOMY AND INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
    Zheng A; Chin EK; Almeida DR; Tsang SH; Mahajan VB
    Retina; 2016 Nov; 36(11):2087-2092. PubMed ID: 27148836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Yutiq - another fluocinolone intravitreal implant for uveitis.
    Med Lett Drugs Ther; 2021 Jul; 63(1629):e5-e6. PubMed ID: 34544110
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
    Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis.
    Oh EK; Lee EK; Yu HG
    Can J Ophthalmol; 2014 Jun; 49(3):273-8. PubMed ID: 24862774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Haritoglou C; Mayer W; Wolf A
    Expert Rev Clin Pharmacol; 2016; 9(3):367-74. PubMed ID: 26681198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of vitrectomy combined with an intraoperative dexamethasone implant in refractory diabetic macular edema.
    Jung YH; Lee Y
    Acta Diabetol; 2019 Jun; 56(6):691-696. PubMed ID: 30824977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.